Published in Biochem J on October 01, 1989
Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol (1992) 2.61
Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J Cell Biol (1990) 1.88
Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol (1992) 1.51
Intracellular proteoglycans. Biochem J (2004) 1.25
Secretory granule proteases in rat mast cells. Cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations. J Exp Med (1997) 1.14
'Heparin'--from anticoagulant drug into the new biology. Glycoconj J (2001) 1.01
Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice. Blood (2007) 0.93
Mast cell proteoglycans. J Histochem Cytochem (2012) 0.92
Serglycin: at the crossroad of inflammation and malignancy. Front Oncol (2014) 0.87
Expression of heparan sulphate L-iduronyl 2-O-sulphotransferase in human kidney 293 cells results in increased D-glucuronyl 2-O-sulphation. Biochem J (2000) 0.85
Sulphation of proteochondroitin and 4-methylumbelliferyl beta-D-xyloside-chondroitin formed by mouse mastocytoma cells cultured in sulphate-deficient medium. Biochem J (1993) 0.80
Assessment of glycosaminoglycan-protein linkage tetrasaccharides as acceptors for GalNAc- and GlcNAc-transferases from mouse mastocytoma. Glycoconj J (1997) 0.79
Heparin proteoglycans synthesized by mouse mastocytoma contain chondroitin sulphate. Biochem J (1995) 0.79
Site-specific identification of heparan and chondroitin sulfate glycosaminoglycans in hybrid proteoglycans. Sci Rep (2016) 0.77
Mast Cells Produce a Unique Chondroitin Sulfate Epitope. J Histochem Cytochem (2015) 0.75
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1990) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
A membrane-filter technique for the detection of complementary DNA. Biochem Biophys Res Commun (1966) 71.25
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem (1981) 71.15
Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J Cell Biol (1975) 36.95
A modified uronic acid carbazole reaction. Anal Biochem (1962) 34.83
How signal sequences maintain cleavage specificity. J Mol Biol (1984) 11.03
Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli. J Virol (1984) 6.73
Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry (1976) 6.00
Structure and biology of proteoglycans. Annu Rev Cell Biol (1988) 2.63
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc Natl Acad Sci U S A (1980) 2.61
Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Lett (1976) 2.34
A proteoglycan form of heparin and its degradation to single-chain molecules. J Biol Chem (1978) 2.18
Molecular cloning and sequence analysis of a chondroitin sulfate proteoglycan cDNA. Proc Natl Acad Sci U S A (1985) 2.08
Identification and synthesis of a recognition signal for the attachment of glycosaminoglycans to proteins. Proc Natl Acad Sci U S A (1987) 2.00
Further characterization of the antithrombin-binding sequence in heparin. Carbohydr Res (1982) 1.83
Relationship of heparan sulfate proteoglycans to the cytoskeleton and extracellular matrix of cultured fibroblasts. J Cell Biol (1984) 1.82
Structure and function of the chemical mediators of mast cells. Prog Allergy (1984) 1.71
Transplantable mastocytoma in the mouse containing histamine, heparin, 5-hydroxytryptamine. Proc Soc Exp Biol Med (1958) 1.65
Intestinal mucosal mast cells from rats infected with Nippostrongylus brasiliensis contain protease-resistant chondroitin sulfate di-B proteoglycans. J Immunol (1986) 1.45
The anticoagulant effect of heparan sulfate and dermatan sulfate. Thromb Res (1976) 1.41
Basophilic leukaemia in the albino rat and a demonstration of the basopoietin. Nat New Biol (1973) 1.39
Complexes of heparin proteoglycans, chondroitin sulfate E proteoglycans, and [3H]diisopropyl fluorophosphate-binding proteins are exocytosed from activated mouse bone marrow-derived mast cells. J Biol Chem (1986) 1.31
Biosynthesis of heparin. Effects of n-butyrate on cultured mast cells. J Biol Chem (1985) 1.23
Glycosaminoglycans in rat mucosal mast cells. Biochem J (1985) 1.19
Identification from cDNA of the precursor form of a chondroitin sulfate proteoglycan core protein. J Biol Chem (1986) 1.15
Purification and characterization of protease-resistant secretory granule proteoglycans containing chondroitin sulfate di-B and heparin-like glycosaminoglycans from rat basophilic leukemia cells. J Biol Chem (1985) 1.14
A novel chromatographic procedure for purification of bacterial plasmids. Anal Biochem (1983) 1.14
Metabolism of cartilage proteins in cultured tissue sections. Biochem J (1983) 1.12
A single gene in mast cells encodes the core peptides of heparin and chondroitin sulfate proteoglycans. Proc Natl Acad Sci U S A (1986) 1.12
Purification and analysis of the core protein of the protease-resistant intracellular chondroitin sulfate E proteoglycan from the interleukin 3-dependent mouse mast cell. J Biol Chem (1985) 1.10
Polydispersity of rat mast cell heparin. Implications for proteoglycan assembly. J Biol Chem (1980) 1.05
Isolation and characterization of a cDNA that encodes the peptide core of the secretory granule proteoglycan of human promyelocytic leukemia HL-60 cells. J Biol Chem (1988) 1.05
Characterization and molecular cloning of the mRNA for the heavy (epsilon) chain of rat immunoglobulin E. Proc Natl Acad Sci U S A (1982) 1.03
Secretory granules of heparin-containing rat serosal mast cells also possess highly sulfated chondroitin sulfate proteoglycans. J Biol Chem (1986) 1.02
Isolation of a cDNA that encodes the peptide core of the secretory granule proteoglycan of rat basophilic leukemia-1 cells and assessment of its homology to the human analogue. J Biol Chem (1988) 0.86
Secretory granule proteoglycans of mast cells and natural killer cells. Ciba Found Symp (1986) 0.82
Gene expression of the chondroitin sulfate proteoglycan core protein PG19. Mol Cell Biol (1987) 0.81
Heparin-like polysaccharides in intra- and extravascular coagulation reactions. Acta Med Scand Suppl (1987) 0.78
Integrin signaling. Science (1999) 16.44
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature (1984) 14.25
Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer (1977) 11.99
The U1 small nuclear RNA-protein complex selectively binds a 5' splice site in vitro. Cell (1983) 9.00
Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell (1985) 8.55
Amount of viral DNA in the genome of cells transformed by adenovirus type 2. J Mol Biol (1973) 8.28
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science (1998) 8.11
Arg-Gly-Asp: a versatile cell recognition signal. Cell (1986) 7.89
Cleavage of adenovirus type 2 DNA into six unique fragments by endonuclease R-RI. Proc Natl Acad Sci U S A (1973) 7.75
Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses. Nature (1979) 6.60
Proteoglycans: structures and interactions. Annu Rev Biochem (1991) 6.53
Production of Acute Gouty Arthritis by Adrenocorticotropin. Science (1949) 6.06
The gene for polypeptide IX of adenovirus type 2 and its unspliced messenger RNA. Cell (1980) 5.80
Severe psoriasis--oral therapy with a new retinoid. Dermatologica (1978) 5.67
Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol (1996) 5.62
Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors. Science (1986) 5.58
Integrins and anoikis. Curr Opin Cell Biol (1997) 5.38
Organ targeting in vivo using phage display peptide libraries. Nature (1996) 5.20
Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell (1990) 5.15
Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci U S A (1984) 5.13
Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature (1990) 4.90
Fibronectin: current concepts of its structure and functions. Coll Relat Res (1981) 4.82
Virus-receptor interaction in an adenovirus system. J Virol (1968) 4.69
The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem (1984) 4.68
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature (1990) 4.64
Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest (1992) 4.49
Fibronectin: purification, immunochemical properties, and biological activities. Methods Enzymol (1982) 4.45
A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc Natl Acad Sci U S A (1985) 4.44
Viral DNA in transformed cells. I. A study of the sequences of adenovirus 2 DNA in a line of transformed rat cells using specific fragments of the viral genome. J Mol Biol (1974) 4.30
Amino acid sequence of the human fibronectin receptor. J Cell Biol (1987) 4.08
Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature (1992) 3.96
Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J (1994) 3.92
Interaction of soluble fibroblast surface antigen with fribrinogen and fibrin. J Exp Med (1975) 3.91
Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol (1997) 3.89
Cleavage maps of DNA from adenovirus types 2 and 5 by restriction endonucleases EcoRI and HpaI. Cold Spring Harb Symp Quant Biol (1975) 3.87
Messenger RNAs from the transforming region of bovine papilloma virus type I. J Mol Biol (1985) 3.73
Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med (1999) 3.72
Isolation of small nuclear ribonucleoproteins containing U1, U2, U4, U5, and U6 RNAs. J Biol Chem (1983) 3.65
Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule. Cell (1981) 3.64
DNA hypomethylation leads to elevated mutation rates. Nature (1998) 3.60
Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med (1978) 3.46
Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2. Proc Natl Acad Sci U S A (1980) 3.45
Structural proteins of adenoviruses. X. Isolation and topography of low molecular weight antigens from the virion of adenovirus type 2. Virology (1973) 3.26
Disappearance of a major cell-type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by Rous sarcoma virus. Int J Cancer (1974) 3.24
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res (2000) 3.24
Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci U S A (1983) 3.23
Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A (1993) 3.16
Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci U S A (1986) 3.16
The human laminin receptor is a member of the integrin family of cell adhesion receptors. Science (1988) 3.03
A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2. Cell (1976) 3.00
Synthetic peptide with cell attachment activity of fibronectin. Proc Natl Acad Sci U S A (1983) 2.97
Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases. Mol Cell Biol (1996) 2.94
Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol (1995) 2.93
The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A (1995) 2.90
Genome of coxsackievirus B3. Virology (1987) 2.88
Multiple domains of the large fibroblast proteoglycan, versican. EMBO J (1989) 2.86
Distribution of fibroblast surface antigen in the developing chick embryo. J Exp Med (1975) 2.85
Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature (1999) 2.82
RNA synthesis and processing in adenovirus-infected cells. Cold Spring Harb Symp Quant Biol (1975) 2.82
Autoantibodies to the U2 small nuclear ribonucleoprotein in a patient with scleroderma-polymyositis overlap syndrome. J Biol Chem (1984) 2.81
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
Regulation of the fibronectin receptor affinity by divalent cations. J Biol Chem (1988) 2.78
Fibroblast surface antigen: a new serum protein. Biochim Biophys Acta (1973) 2.71
Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J (1985) 2.69
Structural proteins of adenoviruses. IV. Sequential degradation of the adenovirus type 2 virion. Virology (1970) 2.65
Viral DNA sequences in cells transformed by simian virus 40, adenovirus type 2 and adenovirus type 5. Cold Spring Harb Symp Quant Biol (1975) 2.65
Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol (1981) 2.65
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest (1998) 2.65
The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci U S A (1985) 2.64
Distribution of fibroblast surface antigen: association with fibrillar structures of normal cells and loss upon viral transformation. J Exp Med (1974) 2.62
Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem (1987) 2.62
Basement membrane glycoprotein laminin binds to heparin. FEBS Lett (1980) 2.60
Cell-surface heparan sulfate: an intercalated membrane proteoglycan. Proc Natl Acad Sci U S A (1981) 2.60
A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1). J Biol Chem (1990) 2.58
Laminin promotes neuritic regeneration from cultured peripheral and central neurons. J Cell Biol (1983) 2.58
Hybridization maps of early and late messenger RNA sequences on the adenovirus type 2 genome. J Mol Biol (1976) 2.58
cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Natl Acad Sci U S A (1986) 2.58
Association of insulin receptor substrate-1 with integrins. Science (1994) 2.56
A stellar relic from the early Milky Way. Nature (2002) 2.56
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest (1990) 2.56
Intranuclear localization of snRNP antigens. J Cell Biol (1986) 2.54
Relationship of mRNA from productively infected cells to the complementary strands of adenovirus type 2 DNA. J Virol (1974) 2.52
Detection of enteroviruses by spot hybridization. J Clin Microbiol (1984) 2.51
Integrin activation by R-ras. Cell (1996) 2.50
Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab (1971) 2.48
Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology (N Y) (1995) 2.45
Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J (1997) 2.40
Structure of two adenovirus type 12 transforming polypeptides and their evolutionary implications. Nature (1980) 2.38
Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science (1996) 2.38
Superfibronectin is a functionally distinct form of fibronectin. Nature (1994) 2.38
Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. J Biol Chem (1993) 2.37
Novel human serum protein from fibroblast plasma membrane. Nature (1974) 2.35
Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol (1999) 2.34
Endothelial cells use alpha 2 beta 1 integrin as a laminin receptor. J Cell Biol (1989) 2.31
Amino acid sequence of the vitronectin receptor alpha subunit and comparative expression of adhesion receptor mRNAs. J Biol Chem (1987) 2.29
Mapping of domains in human laminin using monoclonal antibodies: localization of the neurite-promoting site. J Cell Biol (1986) 2.29
Activation of protein kinase C precedes alpha 5 beta 1 integrin-mediated cell spreading on fibronectin. J Biol Chem (1993) 2.27
Cell surface distribution of fibronectin and vitronectin receptors depends on substrate composition and extracellular matrix accumulation. J Cell Biol (1988) 2.26
Alpha-fetoprotein: immunochemical purification and chemical properties. Expression in normal state and in malignant and non-malignant liver disease. Transplant Rev (1974) 2.26